Previous 10 | Next 10 |
VANCOUVER and HOUSTON, TX , Oct. 18, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announces that Ari Brettman has been appointed ...
ESSA Pharma Inc. (EPIX) [TSX-V: EPI] is a Canadian/U.S. pre-clinical stage pharmaceutical company focused on the development of novel treatments of prostate cancer in patients whose disease is progressing despite treatment with current therapies, including abiraterone and enzalutamide. On ...
ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants Canada NewsWire VANCOUVER and HOUSTON, Oct. 7, 2019 VANCOUVER and HOUSTON , Oct. 7, 2019 /CNW/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceut...
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress Canada NewsWire HOUSTON and VANCOUVER, Sept. 28, 2019 HOUSTON and VANCOUVER , Sept. 28, 2019 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a pharmaceutical ...
ESSA to Present at Ladenburg Thalmann Healthcare Conference Canada NewsWire HOUSTON and VANCOUVER, Sept. 19, 2019 HOUSTON and VANCOUVER , Sept. 19, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focuse...
HOUSTON and VANCOUVER, Sept. 5, 2019 /PRNewswire/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the H.C. ...
ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million Canada NewsWire VANCOUVER and HOUSTON, Aug. 27, 2019 VANCOUVER and HOUSTON , Aug. 27, 2019 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX; TSXV: EPI) ("ESSA...
Gainers : ESSA Pharma (NASDAQ: EPIX ) +26% . Genetic Technologies (NASDAQ: GENE ) +19% . Ocean Power Technologies (NASDAQ: OPTT ) +19% . Ossen Innovation (NASDAQ: OSN ) +13% . Moxian (NASDAQ: MOXC ) +13% . Town Sports International Holdings (NASDAQ: CLUB ) +10% . ClearSign Combustion...
Thinly traded nano cap ESSA Pharma ( EPIX +2.8% ) is up on almost 40% higher volume, albeit on turnover of only 16.4K shares, on the heels of its public offerin g of 18M common shares (or pre-funded warrants) at $2 per share. More news on: ESSA Pharma Inc., Healthcare stocks news, Stock...
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement Canada NewsWire VANCOUVER and HOUSTON, Aug. 23, 2019 VANCOUVER and HOUSTON , Aug. 23, 2019 /CNW/ - ESSA Pharma Inc. (NASDAQ: EPIX; TSXV: EPI) (" ESSA " or the " Company ")...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma to Present at the JonesHealthcare Seaside Summit Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 8, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on de...
ESSA Pharma to Present at the Jefferies Global Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 30, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focus...